Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2025-12-25 @ 8:25 PM
Study NCT ID:
NCT00330369
Status:
COMPLETED
Last Update Posted:
2014-03-18
First Post:
2006-05-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2009-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-24
First Submit QC Date:
None
Study First Post Date:
2006-05-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-02-04
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-02-19
Last Update Post Date:
2014-03-18
Last Update Post Date Type:
ESTIMATED